HOME >> MEDICINE >> NEWS
New Crestor data in African-American patients with high cholesterol

NEW ORLEANS (November 9, 2004) -- New data presented today at the American Heart Association's Annual Scientific Sessions showed that AstraZeneca's CRESTOR (rosuvastatin calcium) at 10 and 20 mg reduced LDL-C or "bad" cholesterol by 37 and 46 percent, compared to 32 and 39 percent at similar doses with atorvastatin in African-American patients. CRESTOR also brought more patients in this study to National Cholesterol Education Program Adult Treatment Panel III (ATP III) LDL-C goals than atorvastatin at milligram-equivalent doses of 10 and 20 mg. ARIES (African American Rosuvastatin Investigation of Efficacy and Safety) is the first-ever large-scale, prospective trial exclusively designed to compare the effects of statins in African-American patients, who have generally been underrepresented in clinical trials.

"As an African American physician who treats a large number of African-American patients, the ARIES trial represents an opportunity to demonstrate the efficacy and safety of statins in this high-risk, undertreated and underserved population," said Dr. Keith C. Ferdinand, clinical cardiologist and medical director of Heartbeats Life Center and the lead investigator for ARIES. "ARIES is the first trial to demonstrate superiority in lowering LDL-cholesterol (bad cholesterol) in this population using rosuvastatin (CRESTOR) compared to atorvastatin, comparing equal doses of each."

ARIES is a six-week, randomized, controlled, open-label, multi-center trial designed to evaluate the efficacy of CRESTOR and atorvastatin in African Americans with elevated cholesterol. After a six-week dietary lead-in, 774 African-American adults with hypercholesterolemia were randomized to one of four open-label treatments for six weeks: CRESTOR 10 or 20 mg or atorvastatin 10 or 20 mg. Results showed CRESTOR 10 and 20 mg reduced LDL-C by 37 and 46 percent respectively compared with 32 and 39 percent for atorvastatin at the same dosages (p<0.017). The data also showed tha
'"/>

Contact: Emily Denney
emily.denney@astrazeneca.com
302-885-3451
Edelman Public Relations
9-Nov-2004


Page: 1 2

Related medicine news :

1. Outstanding efficacy of Crestor (TM) in treating range of patient populations at risk of CVD
2. African-American women with endometrial cancer have more aggressive cancer than Caucasian women
3. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
4. Obesity among African-American stroke survivors increases risk factors for recurrent stroke
5. African-Americans receive less aggressive heart attack treatment
6. African-Americans may need more medication to control asthma
7. Good medicine, good economics: African-Americans need equal treatment for pain, SLU study finds
8. Beliefs may hinder HIV prevention among African-Americans
9. Study suggests obesity has lesser financial impact on African-Americans
10. Sobering disparity: African-Americans receive less compensation for job-related back injuries
11. African-American heart attack patients fare worse long term

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/20/2017)... ... ... Are you an adult with gluten intolerance or Celiac disease living with another ... in a research study that focuses on family interactions when dealing with dietary restrictions. ... of adults who have gluten sensitivities who cohabitate with other adults who may or ...
(Date:8/19/2017)... ... August 19, 2017 , ... The digital health and ... with pending recognition status from the Centers for Disease Control and Prevention (“CDC”) ... and live video conferencing. , The DPP resulted from clinical work conducted ...
(Date:8/19/2017)... ... August 19, 2017 , ... Physician Partners of ... location as an interventional pain management physician. He brings a wealth of pain ... migraine headaches, and significant experience in spinal cord stimulation for chronic pain. , ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... LLC (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions ... definitive agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation ...
(Date:8/18/2017)... O'Fallon, MO (PRWEB) , ... August 18, 2017 , ... ... Charles County, is inaugurating a new charity drive to generate community support for efforts ... for research into cures and treatments for all types of cancer. , Each ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today announced financial ... 2017, and updated its financial outlook for fiscal 2017. ... fiscal third quarter, Hill-Rom reported earnings of $0.09 per ... the prior-year period. These results reflect after-tax special items, ... related to the non-cash write-down of assets associated with ...
(Date:7/27/2017)... Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results ... reported second quarter net sales of $1.954 billion, an ... an increase of 2.1% on a constant currency basis.  ... LDR Holding Corporation acquisition, second quarter 2017 revenues decreased ... on a constant currency basis. ...
(Date:7/26/2017)... 26, 2017 E.I. Medical Imaging (EIMI) has ... SharkLab to custom design the worlds first ultrasound system to be ... their native habitat. In preparation for a piece produced by ... Shark Week, Dr. Guttridge approached EIMI with the idea of ... to hammerhead sharks underwater. ...
Breaking Medicine Technology:
Cached News: